Search results
2-midnight rule could affect 20% of Medicare Advantage patients
Becker’s Hospital Review· 1 day agoCMS' expansion of the two-midnight rule, which could affect more than 20% of Medicare Advantage patients this year, has led to increased inpatient volumes ...
Earnings call: SelectQuote sees growth in Medicare Advantage, raises outlook By Investing.com
Investing.com· 4 days agoSelectQuote, Inc. (SLQT) delivered a confident fiscal third-quarter earnings report, emphasizing...
Here’s why Clover Health stock price spiked after earnings
Invezz· 7 days agoClover Health (NASDAQ: CLOV) stock price went parabolic on Wednesday as investors cheered the...
Mark your calendar: Upcoming events in the Lynchburg area
RockinghamNow.com, Eden and Reidssville· 1 day agoJoin senior care experts from Heritage Green and other dementia care professionals for a free...
I’m 49 and my husband is 59. We have a $2.2 million house and $885,000 saved for retirement. Can we...
Market Watch· 14 hours agoIt sounds like you are doing many things right on your road to retirement, but I do understand why...
Interpreting Indiana's conflict between health insurance and health care in 2024
The Star Press via Yahoo Finance· 2 days agoPrivate physicians often join larger conglomerates to take advantage of economies of scale by...
5 Races To Watch In West Virginia And Maryland On Tuesday
HuffPost via Yahoo News· 19 hours agoA former U.S. Capitol police officer tries to overcome a wave of pro-Israel spending, while...
GUEST EDITORIAL — Independent physician practices are disappearing; that is bad for patients
Around Osceola· 5 days agoCorporate juggernauts are coming to dominate the U.S. healthcare system. UnitedHealth now employs...
Hospitals’ new message for patients: Stay home
Politico· 4 days agoThe appeal to lawmakers is potential savings if remote care proves more efficient, but hospitals also see financial advantage. House legislation that...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Chicago Sun-Times· 5 days agoWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug that July.